
    
      Baseline data include age, gender, pain, sleep condition, family care, tumor type, tumor
      stage, combined disease, chemotherapy regimen and concomitant medication.

      Nutritional risk assessments are performed by the nutrition support team just after
      enrollment, every two cycles of chemotherapy and at the end of the study. The adverse events
      of chemotherapy are collected and recorded at the end of each cycle. CT or MRI is performed
      to evaluate efficacy of chemotherapy every two treatment cycles. Patient after one treatment
      cycle can receive CT or MRI in advance if the clinical condition is worsening.
    
  